Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $37.7900 (-1.54%) ($37.7000 - $37.7900) on Fri. Oct. 15, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.8% (three month average) | RSI | 39 | Latest Price | $37.7900(-1.54%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO advances 0.2% a day on average for past five trading days. | Weekly Trend | HALO declines -3.3% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(51%) IWO(49%) IWM(48%) IWC(45%) IWN(45%) | Factors Impacting HALO price | HALO will decline at least -0.9% in a week (0% probabilities). VIXM(-29%) VXX(-10%) UUP(-10%) GLD(-2%) TBT(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.9% (StdDev 1.8%) | Hourly BBV | 0.2 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $30.2(-20.08%) | Resistance Level | $39.31 | 5 Day Moving Average | $37.38(1.1%) | 10 Day Moving Average | $38.12(-0.87%) | 20 Day Moving Average | $39.31(-3.87%) | To recent high | -12% | To recent low | 3.4% | Market Cap | $5.165b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |